IDEAYA Biosciences, Inc. Contracts & Agreements
65 Contracts & Agreements
- Business Finance (15 contracts)
- Business Operations (16)
- Human Resources (23)
- Intellectual Property (5)
- Real Estate (5)
- Uncategorized (1)
- Employment Agreement by and between IDEAYA Biosciences, Inc. and Douglas Snyder, effective September 18, 2024 (Filed With SEC on November 4, 2024)
- Option and License Agreement by and between IDEAYA Biosciences, Inc. and Biocytogen Pharmaceuticals (Beijing) Co., Ltd., dated July 30, 2024 (Filed With SEC on November 4, 2024)
- Form of Pre-Funded Warrant (Filed With SEC on July 11, 2024)
- Underwriting Agreement, dated as of July 9, 2024, among IDEAYA Biosciences, Inc. and J.P. Morgan Securities LLC, Goldman Sachs & Co. LLC, Jefferies LLC and RBC Capital Markets,... (Filed With SEC on July 11, 2024)
- Clinical Trial Collaboration and Supply Agreement by and between MSD International Business GmbH and IDEAYA Biosciences, Inc., dated as of March 8, 2024 (Filed With SEC on May 7, 2024)
- Office Lease Agreement by and between AAT TORREY 13-14, LLC and IDEAYA Biosciences, Inc. dated as of November 14, 2023 (Filed With SEC on February 20, 2024)
- Clinical Trial Collaboration and Supply Agreement by and between Gilead Sciences, Inc. and IDEAYA Biosciences, Inc. dated as of November 29, 2023 (Filed With SEC on February 20, 2024)
- Non-Employee Director Compensation Program (Filed With SEC on February 20, 2024)
- Description of Common Stock (Filed With SEC on February 20, 2024)
- Open Market Sales Agreement, dated as of January 19, 2024, by and between the Company and Jefferies LLC (Filed With SEC on January 19, 2024)
- Amendment No. 1 to Clinical Trial Collaboration and Supply Agreement (Second Pfizer Agreement), dated as of May 12, 2023, by and between Pfizer Inc. and IDEAYA Biosciences, Inc (Filed With SEC on August 10, 2023)
- Amendment No. 4 to Clinical Trial Collaboration and Supply Agreement (Pfizer Agreement), dated as of May 12, 2023, by and between Pfizer Inc. and IDEAYA Biosciences, Inc (Filed With SEC on August 10, 2023)
- Open Market Sales Agreement, dated as of June 26, 2023, by and between the Company and Jefferies LLC (Filed With SEC on June 30, 2023)
- Form of Pre-Funded Warrant (Filed With SEC on April 27, 2023)
- Underwriting Agreement, dated as of April 24, 2023, among IDEAYA Biosciences, Inc. and J.P. Morgan Securities LLC, Jefferies LLC, and Citigroup Global Markets Inc., as... (Filed With SEC on April 27, 2023)
- Clinical Trial Collaboration and Supply Agreement by and between Amgen Inc. and IDEAYA Biosciences, Inc. made as of July 26, 2022 (Filed With SEC on November 8, 2022)
- Underwriting Agreement, dated as of September 14, 2022, among IDEAYA Biosciences, Inc. and J.P. Morgan Securities LLC, Jefferies LLC, and Citigroup Global Markets Inc., as... (Filed With SEC on September 19, 2022)
- Amendment No. 2 to Collaboration, Option and License Agreement between GlaxoSmithKline Intellectual Property (No. 4) Limited and IDEAYA Biosciences, Inc. effective as of January... (Filed With SEC on May 10, 2022)
- Clinical Trial Collaboration and Supply Agreement between Pfizer Inc. and IDEAYA Biosciences, Inc. dated as of March 9, 2022. (Third Pfizer Agreement) (Filed With SEC on May 10, 2022)
- Clinical Trial Collaboration and Supply Agreement between Pfizer Inc. and IDEAYA Biosciences, Inc. dated as of March 9, 2022. (Second Pfizer Agreement) (Filed With SEC on May 10, 2022)
- Amendment No. 1 to Collaboration, Option and License Agreement between GlaxoSmithKline Intellectual Property (No. 4) Limited and IDEAYA Biosciences, Inc. dated as of October 23,... (Filed With SEC on March 18, 2022)
- Description of Common Stock (Filed With SEC on March 18, 2022)
- Amendment No. 3 to Clinical Trial Collaboration and Supply Agreement between Pfizer Inc. and IDEAYA Biosciences, Inc. dated as of August 9, 2021 (Filed With SEC on November 15, 2021)
- Amended and Restated Employment Agreement between Michael White and IDEAYA Biosciences, Inc. effective as of October 25, 2021 (Filed With SEC on November 15, 2021)
- Underwriting Agreement, dated as of July 7, 2021, among IDEAYA Biosciences, Inc. and J.P. Morgan Securities LLC, Citigroup Global Markets Inc., and Jefferies LLC, as... (Filed With SEC on July 12, 2021)
- Amendment No. 2 to Clinical Trial Collaboration and Supply Agreement between Pfizer Inc. and IDEAYA Biosciences, Inc. dated as of April 8, 2021 (Filed With SEC on May 10, 2021)
- Amended and Restated Employment Agreement by and between IDEAYA Biosciences, Inc. and Jason Throne (Filed With SEC on March 23, 2021)
- Description of Common Stock (Filed With SEC on March 23, 2021)
- Open Market Sale AgreementSM by and between the Company and Jefferies LLC (Filed With SEC on January 21, 2021)
- Amendment No. 1 to Clinical Trial Collaboration and Supply Agreement between Pfizer Inc. and IDEAYA Biosciences, Inc. dated as of September 23, 2020 (Filed With SEC on November 12, 2020)
- Underwriting Agreement, dated as of June 17, 2020, among IDEAYA Biosciences, Inc. and J.P. Morgan Securities LLC, Citigroup Global Markets Inc., and Jefferies LLC, as... (Filed With SEC on June 22, 2020)
- Consulting Agreement by and between IDEAYA Biosciences, Inc. and Julie Hambleton (Filed With SEC on May 12, 2020)
- Clinical Trial Collaboration and Supply Agreement between IDEAYA Biosciences, Inc. and Pfizer Inc. dated as of March 11, 2020 (Filed With SEC on May 12, 2020)
- Transition and Separation Agreement, as amended, by and between IDEAYA Biosciences, Inc. and Julie Hambleton (Filed With SEC on May 12, 2020)
- Employment Agreement by and between IDEAYA Biosciences, Inc. and Jason Throne (Filed With SEC on March 24, 2020)
- Amendment #2 to Evaluation, Option and License Agreement by and among IDEAYA Biosciences, Inc., Cancer Research Technology Ltd. and University of Manchester dated as of March 3,... (Filed With SEC on March 24, 2020)
- Description of Common Stock (Filed With SEC on March 24, 2020)
- Second Amendment to Lease Agreement by and between IDEAYA Biosciences, Inc. and ARE-SAN FRANCISCO NO. 17, LLC dated September 30, 2019 (Filed With SEC on November 13, 2019)
- Employment Agreement by and between IDEAYA Biosciences, Inc. and Julie Hambleton (Filed With SEC on May 17, 2019)
- Employment Agreement by and between IDEAYA Biosciences, Inc. and Jeffrey Hager (Filed With SEC on May 17, 2019)
- Employment Agreement by and between IDEAYA Biosciences, Inc. and Mark Lackner (Filed With SEC on May 17, 2019)
- Employment Agreement by and between IDEAYA Biosciences, Inc. and Paul Stone (Filed With SEC on May 17, 2019)
- Employment Agreement by and between IDEAYA Biosciences, Inc. and Michael Dillon (Filed With SEC on May 17, 2019)
- Form of Restricted Stock Unit Award Grant Notice under the 2019 Incentive Award Plan (Filed With SEC on May 13, 2019)
- 2019 Employee Stock Purchase Plan (Filed With SEC on May 13, 2019)
- Form of Executive Employment Agreement (Filed With SEC on May 13, 2019)
- Employment Agreement by and between IDEAYA Biosciences, Inc. and Yujiro Hata (Filed With SEC on May 13, 2019)
- Non-Employee Director Compensation Program (Filed With SEC on May 13, 2019)
- Form of Indemnification Agreement for directors and officers (Filed With SEC on May 13, 2019)
- Form of Restricted Stock Award Agreement under the 2019 Incentive Award Plan (Filed With SEC on May 13, 2019)
- Form of Stock Option Grant Notice and Stock Option Agreement under the 2019 Incentive Award Plan (Filed With SEC on May 13, 2019)
- 2019 Incentive Award Plan (Filed With SEC on May 13, 2019)
- Form of Underwriting Agreement (Filed With SEC on May 13, 2019)
- Form of Common Stock Certificate (Filed With SEC on May 13, 2019)
- License agreement by and between IDEAYA Biosciences, Inc. and Novartis International Pharmaceutical, Inc. dated as of September 19, 2018 (Filed With SEC on April 26, 2019)
- Evaluation, Option and License Agreement by and among IDEAYA Biosciences, Inc., Cancer Research Technology Ltd. and University of Manchester dated as of April 28, 2017 (Filed With SEC on April 26, 2019)
- Amendment #1 to Evaluation, Option and License Agreement by and among IDEAYA Biosciences, Inc., Cancer Research Technology Ltd. and University of Manchester dated as of April 24,... (Filed With SEC on April 26, 2019)
- Amended and Restated Investors Rights Agreement, by and among IDEAYA Biosciences, Inc. and the investors listed therein, dated January 31, 2018 (Filed With SEC on April 26, 2019)
- 2015 Equity Incentive Plan, as amended (Filed With SEC on April 26, 2019)
- Form of Stock Option Agreement under 2015 Equity Incentive Plan (Filed With SEC on April 26, 2019)
- Form of Early Exercise Stock Option Agreement under 2015 Equity Incentive Plan (Filed With SEC on April 26, 2019)
- Form of Stock Purchase Right Grant Notice and Restricted Stock Purchase Agreement under 2015 Equity Incentive Plan (Filed With SEC on April 26, 2019)
- Lease Agreement by and between IDEAYA Biosciences, Inc. and ARE-SAN FRANCISCO NO. 17, LLC dated August 26, 2016 (Filed With SEC on April 26, 2019)
- Letter Agreement Amendment to Lease Agreement by and between IDEAYA Biosciences, Inc. and ARE-SAN FRANCISCO NO. 17, LLC dated January 27, 2017 (Filed With SEC on April 26, 2019)
- First Amendment to Lease Agreement by and between IDEAYA Biosciences, Inc. and ARE-SAN FRANCISCO NO. 17, LLC dated May 31, 2018 (Filed With SEC on April 26, 2019)
